Bristol-Myers Squibb Co. (BMY) stock analysis and AI prediction
The company facts of Bristol-Myers Squibb Co., with its price and AI prediction for the next 10 market days in SharePreds.
Keep looking in SharePreds
You have looked at today's stocks on this website. SharePreds shows every stock's likelihood of rising, its chart and how its earlier predictions ended, with alerts on the ones you follow.
See all five apps
About Bristol-Myers Squibb Co.
Bristol Myers Squibb discovers, develops, and markets drugs for various therapeutic areas, such as cardiovascular, cancer, and immune disorders. A key focus for Bristol is immuno-oncology, where the firm is a leader in drug development. Bristol derives close to 70% of total sales from the US, showing a higher dependence on the US market than most of its peer group.
- Sector
- Healthcare
- Exchange
- NYSE
- Market value
- $127.4 billion
- Size
- Large cap
- Employees
- 32,500
- Headquarters
- PRINCETON, NJ
- Listed since
- June 23, 1952
- Website
- bms.com
More Healthcare stocks
Other large cap stocks
Keep going
BMY questions
What is the AI prediction for BMY stock?
Each market day our model rates Bristol-Myers Squibb Co. (BMY) Bullish, Neutral or Bearish for the next 10 market days. Predictions are indicative: they rest on price and volume data, and they can be wrong.
How often is the BMY prediction updated?
Each market day, Monday to Friday, except market holidays. The date of the prediction is shown beside it.
What do Bullish, Neutral and Bearish mean?
Bullish means the model sees a rise as likely over the next 10 market days, Bearish a fall, and Neutral no clear direction.
Where can I see the exact likelihood for BMY?
In the SharePreds app for iPhone and Android, with the stock's chart, alerts on it and how its earlier predictions ended.
Where can I see BMY options?
The BMY options page opens its calls and puts, with price, volume, implied volatility and the Greeks.